lactic acid has been researched along with carboplatin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Avall-Lundqvist, E; Hernlund, E; Hjerpe, E; Shoshan, M | 1 |
Harilal, A; Krishnakumar, S; Maheswari, UK; Mitra, M; Mohanty, C; Sahoo, SK | 1 |
Dhanda, DS; Kompella, UB; Mirvish, SS; Tyagi, P | 1 |
Edler, KJ; Gopinathan, N; Lowe, JP; Rigby, SP; Yang, B | 1 |
Arshad, A; Barua, NU; Bienemann, AS; Edler, KJ; Gill, SS; Johnson, DE; Woolley, M; Wyatt, MJ; Yang, B | 1 |
Aleykutty, NA; Cinu, TA; Jose, S; Juna, BC; Jyoti, H | 1 |
Alassaif, ER; Alassaif, FR; Dhanapal, J; Kaushik, AK | 1 |
7 other study(ies) available for lactic acid and carboplatin
Article | Year |
---|---|
Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.
Topics: Antimetabolites; Antineoplastic Agents; Apoptosis; Blotting, Western; Carboplatin; Cell Proliferation; Cisplatin; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Lactic Acid; Mitochondrial Proton-Translocating ATPases; Ovarian Neoplasms; Tumor Cells, Cultured | 2009 |
A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs.
Topics: Antineoplastic Agents; Biocompatible Materials; Carboplatin; Cell Culture Techniques; Cell Proliferation; Cell Survival; Diffusion; Doxorubicin; Etoposide; Extracellular Matrix; Gene Expression Profiling; Humans; Inhibitory Concentration 50; Kinetics; Lactic Acid; MicroRNAs; Nanoparticles; Oligonucleotide Array Sequence Analysis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Retinoblastoma; Tissue Engineering; Tissue Scaffolds | 2012 |
Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzo(a)pyrene; Bronchoalveolar Lavage Fluid; Carboplatin; Celecoxib; Cell Count; Collagen; Delayed-Action Preparations; Female; L-Lactate Dehydrogenase; Lactic Acid; Lung Neoplasms; Mice; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Pulmonary Fibrosis; Pyrazoles; Sulfonamides; Vascular Endothelial Growth Factor A | 2013 |
NMR cryoporometry characterisation studies of the relation between drug release profile and pore structural evolution of polymeric nanoparticles.
Topics: Carboplatin; Cerebrospinal Fluid; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Models, Chemical; Nanoparticles; Nanotechnology; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Porosity; Silicon Dioxide; Solubility; Technology, Pharmaceutical; Transition Temperature | 2014 |
Convection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of Glioblastoma.
Topics: Animals; Carboplatin; Cell Death; Cell Line, Tumor; Cells, Cultured; Convection; Drug Delivery Systems; Endocytosis; Glioblastoma; Hippocampus; Humans; Lactic Acid; Male; Nanoparticles; Neurotoxins; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Sus scrofa | 2015 |
Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
Topics: Animals; Antineoplastic Agents; Brain; Carboplatin; Drug Carriers; Drug Compounding; Drug Liberation; Endocytosis; Factor Analysis, Statistical; Injections, Intraperitoneal; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polysorbates; Rats; Rats, Wistar; Surface Properties | 2016 |
Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles.
Topics: Carboplatin; Chitosan; Drug Carriers; Female; Glycols; Humans; Lactic Acid; Nanoparticles; Ovarian Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |